A 31-year-old Georgia woman is facing a murder charge following a case involving a late-term abortion and the subsequent death of an infant who was born alive, according to court records.
Authorities say Alexia Moore sought medical care on December 30 after experiencing abdominal pain. During her visit, she disclosed to hospital staff that she had taken misoprostol, a medication commonly used in chemical abortions, along with oxycodone. Medical personnel later delivered the premature infant, who survived for approximately one hour but suffered from severe health complications.
Investigators allege that Moore acknowledged her role in taking the abortion-inducing drugs and expressed awareness of the infant’s condition. Law enforcement officials documented these statements in an arrest warrant that formed part of the basis for the charges.
Moore was arrested in early March and has remained in custody at the Camden County jail since March 4. Legal filings indicate that her defense attorney has requested a speedy trial and is also seeking bond.
The case has drawn attention to Georgia’s abortion laws, particularly the 2019 “heartbeat” legislation, which restricts most abortions once fetal cardiac activity is detected, typically around six weeks of pregnancy. The law does allow certain exceptions, including cases involving rape, incest, or threats to the mother’s life up to 20 weeks. However, officials and advocacy groups have emphasized that Moore is not being charged under this statute.
Instead, prosecutors are pursuing the case under broader homicide laws. According to investigators, the infant was considered a legal person under Georgia law because it was born alive, making the circumstances of its death subject to standard criminal statutes.
Court documents indicate Moore reported acquiring the abortion drugs online and obtaining oxycodone from a relative. The case also comes amid ongoing legal and political battles across the United States over access to abortion medications, including disputes over telehealth distribution and federal regulatory oversight.
.jpg)
